JP2017523225A5 - - Google Patents

Download PDF

Info

Publication number
JP2017523225A5
JP2017523225A5 JP2017506964A JP2017506964A JP2017523225A5 JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5 JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017506964 A JP2017506964 A JP 2017506964A JP 2017523225 A5 JP2017523225 A5 JP 2017523225A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
carboxylic acid
formula
heterocycle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017506964A
Other languages
English (en)
Japanese (ja)
Other versions
JP6577570B2 (ja
JP2017523225A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/068257 external-priority patent/WO2016020526A1/en
Publication of JP2017523225A publication Critical patent/JP2017523225A/ja
Publication of JP2017523225A5 publication Critical patent/JP2017523225A5/ja
Application granted granted Critical
Publication of JP6577570B2 publication Critical patent/JP6577570B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017506964A 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類 Expired - Fee Related JP6577570B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14180331.2 2014-08-08
EP14180331 2014-08-08
PCT/EP2015/068257 WO2016020526A1 (en) 2014-08-08 2015-08-07 Indoles for use in influenza virus infection

Publications (3)

Publication Number Publication Date
JP2017523225A JP2017523225A (ja) 2017-08-17
JP2017523225A5 true JP2017523225A5 (enExample) 2019-08-22
JP6577570B2 JP6577570B2 (ja) 2019-09-18

Family

ID=51298610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017506964A Expired - Fee Related JP6577570B2 (ja) 2014-08-08 2015-08-07 インフルエンザウイルス感染に使用するためのインドール類

Country Status (18)

Country Link
US (1) US10597390B2 (enExample)
EP (1) EP3177609A1 (enExample)
JP (1) JP6577570B2 (enExample)
KR (1) KR102488479B1 (enExample)
CN (1) CN106573920B (enExample)
AU (1) AU2015298876B2 (enExample)
BR (1) BR112017002370B1 (enExample)
CA (1) CA2954751C (enExample)
CL (1) CL2017000309A1 (enExample)
EA (1) EA201790266A1 (enExample)
IL (1) IL250408B (enExample)
MA (1) MA40547A (enExample)
MX (1) MX381488B (enExample)
PH (1) PH12017500207B1 (enExample)
SG (1) SG11201700956VA (enExample)
UA (1) UA124609C2 (enExample)
WO (1) WO2016020526A1 (enExample)
ZA (1) ZA201700952B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
JP6577570B2 (ja) 2014-08-08 2019-09-18 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー インフルエンザウイルス感染に使用するためのインドール類
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドVertex Pharmaceuticals Incorporated インフルエンザウイルスの複製の阻害剤を調製する方法
EP3362451B1 (en) 2015-12-09 2023-04-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
EA201891576A1 (ru) * 2016-01-07 2018-11-30 Янссен Сайенсиз Айрлэнд Юси Функционализированные пентановые кислоты для применения при инфекциях, вызванных вирусом гриппа
WO2017133670A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh Pyridine and pyrimidine derivatives and their use in treatment, amelioration or prevention of influenza
WO2018033082A1 (en) * 2016-08-16 2018-02-22 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
CN109641868B (zh) * 2016-08-30 2021-12-03 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
CN110623958B (zh) 2016-09-05 2022-05-17 广东众生睿创生物科技有限公司 抗流感病毒嘧啶衍生物
JP7034162B2 (ja) 2016-12-15 2022-03-11 サンシャイン・レイク・ファーマ・カンパニー・リミテッド インフルエンザウイルス複製の阻害剤及びその使用
US11542233B2 (en) * 2016-12-23 2023-01-03 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use
WO2018127096A1 (en) 2017-01-05 2018-07-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CN110446711B (zh) 2017-03-02 2022-02-15 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
KR102484804B1 (ko) * 2018-03-05 2023-01-04 광둥 레이노벤트 바이오테크 컴퍼니 리미티드 이미다졸계 화합물의 결정 형태, 염 형태 및 그의 제조 방법
US12252487B2 (en) 2019-07-22 2025-03-18 Guangdong Raynovent Biotech Co., Ltd. Dominant salt forms of pyrimidine derivatives, and crystal forms thereof
CN113045475A (zh) * 2019-12-27 2021-06-29 上海泓博智源医药股份有限公司 一种5-溴-7-甲基吲哚的制备方法
WO2022020342A1 (en) * 2020-07-20 2022-01-27 Nido Biosciences, Inc. Indole compounds as androgen receptor modulators
US20240010643A1 (en) * 2020-09-18 2024-01-11 Sunshine Lake Pharma Co., Ltd. Preparation method of substituted pyrimidine piperazine compounds
IL320191A (en) * 2022-10-12 2025-06-01 Maze Therapeutics Inc Solute carrier family 6A member 19 inhibitors (SLC6A19) and methods of using them

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2560454C (en) 2004-03-30 2013-05-21 Vertex Pharmaceuticals Incorporated Azaindoles useful as inhibitors of jak and other protein kinases
EP2537849A3 (en) 2006-01-17 2013-04-03 Vertex Pharmaceuticals, Inc. Azaindoles useful as inhibitors of janus kinases
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
US9326987B2 (en) * 2010-09-08 2016-05-03 Glaxo Group Limited Indazole derivatives for use in the treatment of influenza virus infection
WO2012083122A1 (en) 2010-12-16 2012-06-21 Vertex Pharmaceutical Incorporated Inhibitors of influenza viruses replication
CN103492381A (zh) * 2010-12-16 2014-01-01 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
EP2763990B1 (en) 2011-09-01 2017-02-22 F. Hoffmann-La Roche AG Pyrrolopyrazine kinase inhibitors
WO2013184985A1 (en) 2012-06-08 2013-12-12 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
HRP20191525T1 (hr) 2013-11-13 2019-11-29 Vertex Pharma Inhibitori replikacije virusa influence
AR101401A1 (es) 2014-08-08 2016-12-14 Bayer Cropscience Ag Derivados de bipirazol, sustituidos con halógeno
JP6577570B2 (ja) 2014-08-08 2019-09-18 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー インフルエンザウイルス感染に使用するためのインドール類
AR101448A1 (es) 2014-08-08 2016-12-21 Bayer Cropscience Ag Compuestos sustituidos por halógeno
CN104592038A (zh) 2015-01-12 2015-05-06 烟台万润精细化工股份有限公司 一种5,5-二甲基-1,3-环己二胺的制备方法

Similar Documents

Publication Publication Date Title
JP2017523225A5 (enExample)
JP2015024998A5 (enExample)
JP2020507589A5 (enExample)
JP2017531619A5 (enExample)
ZA202006378B (en) N-heterocyclic five-membered ring-containing capsid protein assembly inhibitor, pharmaceutical composition thereof, and use thereof
JP2019501879A5 (enExample)
JP2019509276A5 (enExample)
JP2016518434A5 (enExample)
JP2020531422A5 (enExample)
JP2017531038A5 (enExample)
JP2020532547A5 (enExample)
EA201992082A1 (ru) Ингибитор поверхностного антигена вируса гепатита b
JP2017517565A5 (enExample)
JP2017528503A5 (enExample)
RU2013121788A (ru) Ингибиторы репликации вич
HRP20211278T1 (hr) Supstituirani derivati indolina kao inhibitori replikacije denga virusa
JP2014511891A5 (enExample)
JP2013542247A5 (enExample)
JP2019500387A5 (enExample)
JP2013543896A5 (enExample)
HRP20210038T1 (hr) Pirolopirimidini za uporabu u infekciji virusom gripe
JP2016534063A5 (enExample)
JP2016510326A5 (enExample)
JP2015051983A5 (enExample)
HRP20211223T1 (hr) Heterociklički indoli za upotrebu kod infekcije virusom influence